Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines

BMC Veterinary Research

Shigeru Morikawa⁸  Shigeru Kyuwa⁴  Yasuhiro Yoshikawa⁴  Hiroomi Akashi⁷  Masayuki Saijo⁸  Yoshiyuki Ishii⁴  Tetsuya Mizutani⁸  Shuetsu Fukushi⁸  Itoe Iizuka¹  Shumpei Watanabe⁸  Mary E Miranda³  Tetsuro Ikegami²  Noriyo Nagata⁶  Yusuke Sayama⁵  Satoshi Taniguchi⁴ 

[1]Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

[2]Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, Mary Moody Northen Pavilion 3.206D, 301 University Boulevard Galveston, Texas, TX, 77555-0436, USA

[3]Veterinary Public Health Specialist, Aralia St., Ayala Westgrove Heights, Silang, Cavite, 4118, Philippines

[4]Department of Biomedical Science, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan

[5]Department of Virology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Japan

[6]Department of Pathology, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan

[7]Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan

[8]Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan

关键词: Antibody;    Cytokine;    Cynomolgus macaque;    Humoral immune response;    Zoonosis;    Filovirus;    Reston ebolavirus;    Reston virus;    Ebolavirus;    Ebola;   

Others  :  1119698
DOI  :  10.1186/1746-6148-8-189

 received in 2012-06-15, accepted in 2012-10-04,  发布年份 2012

【 摘 要 】

Background

Ebolaviruses induce lethal viral hemorrhagic fevers (VHFs) in humans and non-human primates, with the exceptions of Reston virus (RESTV), which is not pathogenic for humans. In human VHF cases, extensive analyses of the humoral immune responses in survivors and non-survivors have shown that the IgG responses to nucleoprotein (NP) and other viral proteins are associated with asymptomatic and survival outcomes, and that the neutralizing antibody responses targeting ebolaviruses glycoprotein (GP_1,2) are the major indicator of protective immunity. On the other hand, the immune responses in non-human primates, especially naturally infected ones, have not yet been elucidated in detail, and the significance of the antibody responses against NP and GP_1,2 in RESTV-infected cynomolgus macaques is still unclear. In this study, we analyzed the humoral immune responses of cynomolgus macaque by using serum specimens obtained from the RESTV epizootic in 1996 in the Philippines to expand our knowledge on the immune responses in naturally RESTV-infected non-human primates.

Results

The antibody responses were analyzed using IgG-ELISA, an indirect immunofluorescent antibody assay (IFA), and a pseudotyped VSV-based neutralizing (NT) assay. Antigen-capture (Ag)-ELISA was also performed to detect viral antigens in the serum specimens. We found that the anti-GP_1,2 responses, but not the anti-NP responses, closely were correlated with the neutralization responses, as well as the clearance of viremia in the sera of the RESTV-infected cynomolgus macaques. Additionally, by analyzing the cytokine/chemokine concentrations of these serum specimens, we found high concentrations of proinflammatory cytokines/chemokines, such as IFNγ, IL8, IL-12, and MIP1α, in the convalescent phase sera.

Conclusions

These results imply that both the antibody response to GP_1,2 and the proinflammatory innate responses play significant roles in the recovery from RESTV infection in cynomolgus macaques.

【 授权许可】

   
2012 Taniguchi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Kuhn JH, Becker S, Ebihara H, Geisbert TW, Jahrling PB, Kawaoka Y, Netesov SV, Nichol ST, Peters CJ, Volchkov VE, Ksiazek TG: Family _filoviridae. In Virus taxonomy - ninth report of the international committee on taxonomy of viruses. Edited by King Andrew MQ, Adams Michael J, Carstens Eric B, Lefkowitz Elliot J. London, United Kingdom: Elsevier/Academic Press; 2011:665-671.
• [2]Morikawa S, Saijo M, Kurane I: Current knowledge on lower virulence of Reston Ebola virus (in French: connaissances actuelles sur la moindre virulence du virus Ebola Reston). Comp Immunol Microbiol Infect Dis 2007, 30(5–6):391-398.
• [3]Ikegami T, Miranda ME, Calaor AB, Manalo DL, Miranda NJ, Niikura M, Saijo M, Une Y, Nomura Y, Kurane I, et al.: Histopathology of natural Ebola virus subtype Reston infection in cynomolgus macaques during the Philippine outbreak in 1996. Exp Anim 2002, 51(5):447-455.
• [4]Miranda ME, Miranda NL: Reston ebolavirus in humans and animals in the Philippines: a review. J Infect Dis 2011, 204(Suppl 3):S757-S760.
• [5]Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh WJ, Batten B, et al.: Discovery of swine as a host for the Reston ebolavirus. Science 2009, 325(5937):204-206.
• [6]Saijo M, Niikura M, Morikawa S, Ksiazek TG, Meyer RF, Peters CJ, Kurane I: Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol 2001, 39(1):1-7.
• [7]Ikegami T, Saijo M, Niikura M, Miranda ME, Calaor AB, Hernandez M, Manalo DL, Kurane I, Yoshikawa Y, Morikawa S: Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus. Epidemiol Infect 2003, 130(3):533-539.
• [8]Ikegami T, Saijo M, Niikura M, Miranda ME, Calaor AB, Hernandez M, Manalo DL, Kurane I, Yoshikawa Y, Morikawa S: Development of an immunofluorescence method for the detection of antibodies to ebola virus subtype Reston by the use of recombinant nucleoprotein-expressing HeLa cells. Microbiol Immunol 2002, 46(9):633-638.
• [9]Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ: Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in ebola virus-infected patients. Nat Med 1999, 5(4):423-426.
• [10]Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM: Human fatal Zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010, 4(10):e837.
• [11]Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, Lacasse RA, Gardner D, Feldmann H: Host response dynamics following lethal infection of Rhesus macaques with Zaire ebolavirus. J Infect Dis 2011, 204(Suppl 3):S991-S999.
• [12]Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debre P, McCormick JB, Georges AJ: Human asymptomatic ebola infection and strong inflammatory response. Lancet 2000, 355(9222):2210-2215.
• [13]Gupta M, MacNeil A, Reed ZD, Rollin PE, Spiropoulou CF: Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus. Virology 2012, 423(2):119-124.
• [14]Hutchinson KL, Villinger F, Miranda ME, Ksiazek TG, Peters CJ, Rollin PE: Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with ebola virus (Reston serotype). J Med Virol 2001, 65(3):561-566.
• [15]Ikegami T, Niikura M, Saijo M, Miranda ME, Calaor AB, Hernandez M, Acosta LP, Manalo DL, Kurane I, Yoshikawa Y, et al.: Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston ebola virus nucleoprotein. Clin Diagn Lab Immunol 2003, 10(4):552-557.
• [16]Taniguchi S, Watanabe S, Masangkay JS, Omatsu T, Ikegami T, Alviola P, Ueda N, Iha K, Fujii H, Ishii Y, et al.: Reston ebolavirus antibodies in bats, the Philippines. Emerg Infect Dis 2011, 17(8):1559-1560.
• [17]Sayama Y, Demetria C, Saito M, Azul RR, Taniguchi S, Fukushi S, Yoshikawa T, Iizuka I, Mizutani T, Kurane I, et al.: A seroepidemiologic study of Reston ebolavirus in swine in the Philippines. BMC Vet Res 2012, 8:82. BioMed Central Full Text
• [18]Rollin PE, Williams RJ, Bressler DS, Pearson S, Cottingham M, Pucak G, Sanchez A, Trappier SG, Peters RL, Greer PW, et al.: Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 1999, 179(Suppl 1):S108-S114.
• [19]Hensley LE, Young HA, Jahrling PB, Geisbert TW: Proinflammatory response during ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002, 80(3):169-179.
• [20]Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, Lansoud-Soukate J, Mavoungou E: Inflammatory responses in ebola virus-infected patients. Clin Exp Immunol 2002, 128(1):163-168.
• [21]Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK: Epitopes involved in antibody-mediated protection from ebola virus. Science 2000, 287(5458):1664-1666.
• [22]Prehaud C, Hellebrand E, Coudrier D, Volchkov VE, Volchkova VA, Feldmann H, Le Guenno B, Bouloy M: Recombinant ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol 1998, 79(Pt 11):2565-2572.
• [23]Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H: Release of viral glycoproteins during ebola virus infection. Virology 1998, 245(1):110-119.
• [24]Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, Rollin PE: Analysis of human peripheral blood samples from fatal and nonfatal cases of ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004, 78(19):10370-10377.
• [25]Bray M, Geisbert TW: Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of ebola hemorrhagic fever. Int J Biochem Cell Biol 2005, 37(8):1560-1566.
• [26]Bray M, Mahanty S: Ebola hemorrhagic fever and septic shock. J Infect Dis 2003, 188(11):1613-1617.
• [27]Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A, Fulhorst CF, Rollin PE, Calaor AB, Manalo DL, Roces MC, et al.: Epidemiology of ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis 1999, 179(Suppl 1):S115-S119.
• [28]Ikegami T, Calaor AB, Miranda ME, Niikura M, Saijo M, Kurane I, Yoshikawa Y, Morikawa S: Genome structure of ebola virus subtype Reston: differences among ebola subtypes. Brief report. Arch Virol 2001, 146(10):2021-2027.
• [29]Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S: Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 2005, 86(Pt 8):2269-2274.
• [30]Saijo M, Ami Y, Suzaki Y, Nagata N, Iwata N, Hasegawa H, Ogata M, Fukushi S, Mizutani T, Sata T, et al.: LC16m8, A highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. J Virol 2006, 80(11):5179-5188.